Olaf Schermeier

Olaf Schermeier

Director/Board Member at
Medos Medizintechnik AG
53 year
Health Technology
Consumer Services
Health Services

Profile

Currently, Olaf Schermeier is CEO-Global Research & Development at Fresenius Medical Care AG & Co. KGaA and Chairman-Supervisory Board for Xenios AG (a subsidiary of Fresenius Medical Care AG & Co. KGaA). Dr. Schermeier is also on the board of Medos Medizintechnik AG and Member of Stifterverband für die Deutsche Wissenschaft eV, Member-Management Board at Fresenius Medical Care Management AG and Member-Administration Board at Unicyte AG. In the past Olaf Schermeier occupied the position of Manager-Strategic Product Planning at BIOTRONIK SE & Co. KG, Development Engineer at Robodent GmbH, President-Global Research & Development at Dräger Medical GmbH and Research Engineer at Charité - Universitätsmedizin Berlin. Dr. Schermeier received a doctorate from Technical University of Berlin and an undergraduate degree from the University of Hannover.

Olaf Schermeier active positions

CompaniesPositionStart
Stifterverband für die Deutsche Wissenschaft eV
Corporate Officer/Principal -
Director/Board Member 01/01/2018
Corporate Officer/Principal -

Former positions of Olaf Schermeier

CompaniesPositionEnd
Corporate Officer/Principal 01/01/2022
Director/Board Member 06/10/2016
Chief Tech/Sci/R&D Officer 01/02/2013
Corporate Officer/Principal 01/01/2004
Robodent GmbH
Corporate Officer/Principal 01/01/2002
See the detail of Olaf Schermeier's experience

Training of Olaf Schermeier

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Stifterverband für die Deutsche Wissenschaft eV

Distribution Services

Health Technology

Health Technology

Commercial Services

Robodent GmbH

  1. Stock Market
  2. Insiders
  3. Olaf Schermeier
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!